key: cord-0259639-0fko98qd authors: Blanco, I.; Violan, C.; Suner, C.; Garcia-Prieto, J.; Argerich, M. J.; Rodriguez-Illana, M.; Moreno, N.; Cardona, P.-J.; Blanco, A.; Toran-Montserrat, P.; Clotet, B.; Bonet, J. M.; Prat, N. title: Comparison between mid-nasal swabs and buccal swabs for SARS-CoV-2 detection in mild COVID-19 patients date: 2022-01-23 journal: nan DOI: 10.1101/2022.01.20.22269539 sha: d9b66b4c009c70eb461e76a3ac7010cff340321a doc_id: 259639 cord_uid: 0fko98qd Background The use of rapid antigen diagnostics tests (Ag-RDT) has gained widespread acceptance as an alternative method for diagnosis of COVID-19 outside of health care settings. Various authors have reported that saliva is a reliable specimen, alternative to nasopharyngeal and mid-nasal swabs, to detect SARS-CoV-2 infections by RT-PCR. We assessed the performance of buccal swabs containing saliva for SARS-CoV-2 detection by Ag-RDT, using mid-nasal specimens as a reference in the northern area of Barcelona (Catalonia, Spain) Methods In the context of routine clinical diagnosis of mild COVID-19 patients, we enrolled 300 adults in a study to directly compare mid-nasal swabs and saliva specimens for SARS-CoV-2 detection by Ag-RDT. When mid-nasal and buccal Ag-RDTs showed discordant results, a third mid-nasal swab was collected and analysed by RT-PCR. Results Paired samples were successfully obtained in 300 suspected cases of SARS-CoV-2 infection. Of the 300 paired samples, Ag-RDT with the mid-nasal swab detected 139 (46.3%) positive COVID-19 cases. In comparison, buccal swabs showed a sensitivity and specificity of 31.7% (44/139) and 98.8% (159/161), respectively. 65 discordant results with positive mid-nasal swabs and negative buccal swabs were tested by RT-qPCR. All samples tested by Rt-PCR resulted positive, with a mean cycle threshold (Ct) of 28.3 (SD 7.3). Conclusion Our findings show that mid-nasal swabs have better performance than buccal swabs for detecting SARS-CoV-2 with Ag-RDT tests. Of note, the sensitivity of buccal samples was affected in samples with high viral loads (Ct<33), suggesting that buccal swabs might not be sensitive enough to detect individuals at risk of transmission. Taken together, the existing literature and the results provided in our analysis we advise against the use of buccal specimens for SARS-CoV-2 diagnostics with Ag-RDT. Pere Torán-Monserrat, MD 2 Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari per a la recerca a l'Atenció Primària Jordi Gol i Gurina (IDIAP J Gol). 3 The use of rapid antigen diagnostics tests (Ag-RDT) has gained widespread acceptance as an alternative method for diagnosis of COVID-19 outside of health care settings. Ag-RDT offer advantages as they can be deployed by members of the general public, which require the use of self-collected specimens. Various authors have reported that saliva is a reliable specimen, alternative to nasopharyngeal and mid-nasal swabs, to detect SARS- In the context of routine clinical diagnosis of mild COVID-19 patients, we enrolled 300 adults in a study to directly compare mid-nasal swabs and saliva specimens for SARS- perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 23, 2022. In summary, our findings show that mid-nasal swabs have better performance than buccal swabs for detecting SARS-CoV-2 with Ag-RDT tests. Of note, the sensitivity of buccal samples was affected in samples with high viral loads (Ct<33) 9 , suggesting that buccal swabs are not sensitive enough to detect individuals at risk of transmission. Regarding the usability of buccal swab samples, due to the previous coughing step and the time required for its collection, they imply a higher exposure of the health worker to the potentially infected person. Taken together, the existing literature and the results provided in our analysis we advise against the use of buccal specimens for SARS-CoV-2 diagnostics with Ag-RDT. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 23, 2022. ; https://doi.org/10.1101/2022.01.20.22269539 doi: medRxiv preprint perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 23, 2022. ; https://doi.org/10.1101/2022.01.20.22269539 doi: medRxiv preprint Self-collected mid-nasal swabs and saliva specimens, compared with nasopharyngeal swabs, for SARS-CoV-2 detection in mild COVID-19 patients Viral dynamics of SARS-CoV-2 in saliva from infected patients Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2 Validation and implementation of a direct RT-qPCR method for rapid screening of SARS-CoV-2 infection by using non-invasive saliva samples Detection of SARS-CoV-2 by rapid antigen tests on saliva in hospitalized patients with COVID-19 Efficacy and validity of automated quantitative chemiluminescent enzyme immunoassay for SARS-CoV-2 antigen test from saliva specimen in the diagnosis of COVID-19 Considerations for the use of saliva as sample material for COVID-19 testing Saliva swabs are the preferred sample for Omicron detection Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards Diagnostic Salivary Tests for SARS-CoV-2 We thank the North Metropolitan Management for the support in the development of the project. We thank the personnel from the Centralized Support Unit COVID-19 (UCSC), Primary care emergency centres and Northern Metropolitan Clinic Laboratories for their support in administration, human resources, and supply chain management. The authors declare no conflicts of interest. The study received support and funded of the Gerencia Territorial Metropolitana Nord, Direcció Atenció Primària Metropolitana Nord, Hospital Universitari Germans Trias i Pujol (Institut Català de la Salut) . The study was conducted according to the Helsinki Declaration of the World Medical Association. The study protocol was approved by the Ethics Committee at IDIAP Jordi Gol and the institutional review boards of participating centres (P22/022). All patients provided written informed consent before enrolling the study, which was supervised by an independent data and safety monitoring board. All data produced in the present study are available upon reasonable request to the authors.